This page shows the latest CMA news and features for those working in and with pharma, biotech and healthcare.
The EMA announced today that it had received an application for conditional marketing authorisation (CMA) for AZ/Oxford’s COVID-19 vaccine. ... In December 2020, the EC also authorised a CMA for Pfizer/BioNTech’s COVID-19 vaccine, now known as
Authorisation closely follows CHMP recommendation. The European Commission has granted Pfizer/BioNTech's COVID-19 vaccine a conditional market authorisation (CMA) on the same day that the European Medicines Agency's ... Under the CMA process, the
The company is also set to apply for a Conditional Marketing Authorisation (CMA) application with the European Medicines Agency (EMA), priming itself to score regulatory approval for the vaccine on both
The main concern posed by the CMA and the FTC is that the newly merged company could have an overly dominant position in the haemophilia A market. ... The FTC and CMA investigation into the merger was a surprise for not only Spark, but the entire pharma
Roche first announced its intention to acquire Spark in February, but has had to keep pushing back the completion date as the FTC in the US and the CMA in the ... In a statement from the CMA, the antitrust authority said: “While gene therapy treatments
The case dates back to 2015, when the Competition and Markets Authority (CMA) accused the two companies of dramatically raising the price of phenytoin sodium, a drug that has been used ... A report in the Financial Times says the CMA is arguing
More from news
Approximately 5 fully matching, plus 13 partially matching documents found.
A firm pharma focus. The CMA’s focus on the pharmaceutical industry is not surprising. ... cartel activities and serious abuses of a dominant position, which the CMA categorises.
The Advertising Standards Authority (ASA) and Competitions and Markets Authority (CMA) have been applying stricter guidelines and monitoring the industry more closely. ... Always seek advice from the agency you’re working with or directly from the ASA
The use of real-world evidence (RWE) as a complement to clinical trial data to support reimbursement decisions after Conditional Marketing Authorisation (CMA) is granted.
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...